feed,title,long_url,short_url
Benzinga,Amgen's Olpasiran Reduced Cholesterol Levels In 95% Of Patients In Mid-Stage Study,https://benzinga.com/general/biotech/22/11/29592929/amgens-olpasiran-reduced-cholesterol-levels-in-95-of-patients-in-mid-stage-study,https://bit.ly/3FUAWGq
